
Adaptyv Biosystems
Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
About
Adaptyv Bio provides an automated lab service for agentic biology, enabling rapid protein validation from sequence design to experimental data in under three weeks. Their all-in-one platform allows users to upload protein designs, choose data types, and receive high-quality experimental results, purpose-built for AI-first protein engineering. They serve leading protein design teams by delivering clean, experimental data to train and improve AI models.
Key facts
At-a-glance profile data
- Website
- adaptyvbio.com
- Headquarters
- Lausanne, Switzerland
- Founded
- 2021
- Employees
- 25
- Total funding
- $40M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 26 Aug 2026 | Series A | $40M | Highland Europe |
Tech stack
Detected on adaptyvbio.com, last scanned 27 Aug 2026. Run your own scan
- Frontend
- Next.js, Tailwind CSS
- SEO
- Short.io
- CMS / Builders
- Framer
- CDN
- Vercel
- Email provider
- Google Workspace
Frequently asked
Is Adaptyv Biosystems trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Adaptyv Biosystems is 82 out of 100, based on site security posture and privacy practices.
How much funding has Adaptyv Biosystems raised?
Adaptyv Biosystems has raised a total of $40M in funding. The most recent round on record is Series A.
How many employees does Adaptyv Biosystems have?
Adaptyv Biosystems has approximately 25 people on record.
